Literature DB >> 12414126

Synergistic interaction of estradiol and insulin-like growth factor-I in the activation of PI3K/Akt signaling in the adult rat hypothalamus.

Gloria Patricia Cardona-Gomez1, Pablo Mendez, Luis Miguel Garcia-Segura.   

Abstract

Estradiol and insulin-like growth factor-I (IGF-I) interact in the hypothalamus to regulate neuronal function, synaptic plasticity and neuroendocrine events. However, the molecular mechanisms involved in these interactions are still unknown. In the present study, the effect of estradiol on the signaling pathways of IGF-I receptor has been assessed in the hypothalamus of young adult ovariectomized rats, using specific antibodies for the phosphorylated forms of extracellular-signal regulated kinase (ERK) 1 and ERK2 and Akt/protein kinase B (Akt/PKB). Estradiol treatment resulted, between 6 and 24 h after systemic administration, in dose-dependent effects on the phosphorylation of ERK and Akt/PKB. Estradiol did not modify the level of ERK phosphorylation induced by intracerebroventricular administration of IGF-I. However, both hormones had a synergistic effect on the phosphorylation of Akt/PKB. These findings suggest that estrogen effects in the hypothalamus may be mediated in part by the activation of the signaling pathways of the IGF-I receptor.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12414126     DOI: 10.1016/s0169-328x(02)00449-7

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  35 in total

1.  Suppression subtractive hybridization and microarray identification of estrogen-regulated hypothalamic genes.

Authors:  Anna Malyala; Patrick Pattee; Srinivasa R Nagalla; Martin J Kelly; Oline K Rønnekleiv
Journal:  Neurochem Res       Date:  2004-06       Impact factor: 3.996

2.  Aging and substitutive hormonal therapy influence in regional and subcellular distribution of ERα in female rat brain.

Authors:  Ana Navarro; Eva Del Valle; Cristina Ordóñez; Eva Martínez; Cristina Pérez; Ana Alonso; Celestino González; Jorge Tolivia
Journal:  Age (Dordr)       Date:  2012-05-10

Review 3.  Multiple pathways transmit neuroprotective effects of gonadal steroids.

Authors:  Damani N Bryant; Laird C Sheldahl; Lisa K Marriott; Robert A Shapiro; Daniel M Dorsa
Journal:  Endocrine       Date:  2006-04       Impact factor: 3.633

4.  17beta-estradiol attenuates glycogen synthase kinase-3beta activation and tau hyperphosphorylation in Akt-independent manner.

Authors:  Hai-Rong Shi; Ling-Qiang Zhu; Shao-Hui Wang; Xin-An Liu; Qing Tian; Qi Zhang; Qun Wang; Jian-Zhi Wang
Journal:  J Neural Transm (Vienna)       Date:  2008-01-24       Impact factor: 3.575

Review 5.  Influences of manganese on pubertal development.

Authors:  William L Dees; Jill K Hiney; Vinod K Srivastava
Journal:  J Endocrinol       Date:  2017-07-18       Impact factor: 4.286

Review 6.  Importance of sex to pain and its amelioration; relevance of spinal estrogens and its membrane receptors.

Authors:  Alan R Gintzler; Nai-Jiang Liu
Journal:  Front Neuroendocrinol       Date:  2012-10-02       Impact factor: 8.606

7.  Neuroprotective effects of estradiol on motoneurons in a model of rat spinal cord embryonic explants.

Authors:  Andrea Cardona-Rossinyol; Margalida Mir; Víctor Caraballo-Miralles; Jerònia Lladó; Gabriel Olmos
Journal:  Cell Mol Neurobiol       Date:  2013-01-16       Impact factor: 5.046

Review 8.  Membrane estrogen receptors activate metabotropic glutamate receptors to influence nervous system physiology.

Authors:  Marissa I Boulware; Paul G Mermelstein
Journal:  Steroids       Date:  2008-11-25       Impact factor: 2.668

9.  Short-term alcohol administration alters KiSS-1 gene expression in the reproductive hypothalamus of prepubertal female rats.

Authors:  Vinod K Srivastava; Jill K Hiney; W Les Dees
Journal:  Alcohol Clin Exp Res       Date:  2009-06-10       Impact factor: 3.455

10.  Neuroprotective actions of selective estrogen receptor modulators.

Authors:  Lydia L DonCarlos; Iñigo Azcoitia; Luis M Garcia-Segura
Journal:  Psychoneuroendocrinology       Date:  2009-12       Impact factor: 4.905

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.